Improved oxygenation by nitric oxide is enhanced by prior lung reaeration with surfactant, rather than positive end-expiratory pressure, in lung-lavaged rabbits

Critical Care Medicine

Volumn 25, Issue 11, 1997, Pages 1868-1873

  Gommers, Diederik ^a   Hartog, Arthur ^a   Van 'T Veen, Annemarie ^a   Lachmann, Burkhard ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Critical illness; Disease models, animal; Lung; Nitric oxide; Pulmonary gas exchange; Pulmonary surfactants; Respiratory distress syndrome; Respiratory mechanics

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTICLE; BREATHING MECHANICS; CRITICAL ILLNESS; LUNG ALVEOLUS SURFACE TENSION; LUNG DIFFUSION; LUNG GAS EXCHANGE; LUNG INJURY; NONHUMAN; OXYGEN TISSUE LEVEL; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, INHALATION; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFANT, NEWBORN; NITRIC OXIDE; POSITIVE-PRESSURE RESPIRATION; PULMONARY GAS EXCHANGE; RABBITS; RESPIRATORY INSUFFICIENCY; SURFACE-ACTIVE AGENTS;

EID: 0030730543     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199711000-00027     Document Type: Article

References (32)

1. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526
2. Roberts JD, Polaner DM, Lang P, et al: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:818-819
3. Kinsella JP, Neish SR, Shaffer E, et al: Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:819-820
4. Rossaint R, Falke KJ, López F, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405
5. Gerlach H, Rossaint R, Pappert D, et al: Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23:499-502
6. Bigatello LM, Hurford WE, Kacmarek RM, et al: Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 1994; 80: 761-770
7. Puybasset L, Rouby J-J, Mourgeon E, et al: Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Respir Crit Care Med 1995; 152:318-328
8. Gaston B, Drazen JM, Loscalzo J, et al: The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-551
9. Kinsella JP, Abman SH: Efficacy of inhalational nitric oxide therapy in the clinical management of persistent pulmonary hypertension of the newborn. Chest 1994; 105:92S-94S
10. Wilcox DT, Glick PL, Karamanoukian HL, et al: Perfluorocarbon-associated gas exchange improves pulmonary mechanics, oxygenation, ventilation, and allows nitric oxide delivery in the hypoplastic lung congenital diaphragmatic hernia Iamb model. Crit Care Med 1995; 23:1858-1863
11. Lachmann B, Robertson B, Vogel J: In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand 1980; 24:231-236
12. Gommers D, Vilstrup C, Bos JAH, et al: Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Crit Care Med 1993; 21:567-574
13. Karamanoukian HL, Glick PL, Wilcox DT, et al: Pathophysiology of congenital diaphragmatic hernia VIII: Inhaled nitric oxide requires exogenous surfactant therapy in the lamb model of congenital diaphragmatic hernia. J Pediatr Surg 1995; 30:1-4
14. Jobe AH: Pulmonary surfactant therapy. N Engl J Med 1993; 328:861-868
15. Lachmann B, Eijking EP, So KL, et al: In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 1994; 20:6-11
16. Gommers D, Lachmann B: Surfactant therapy perspectives in adult patients. Curr Opin Crit Care 1995; 1:57-61
17. Benzing A, Brautigam P, Geiger K, et al: Inhaled nitric oxide reduces pulmonary transvascular albumin flux in patients with acute lung injury. Anesthesiology 1995; 83:1153-1161
18. Putensen C, Räsänen J, López FA, et al: Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation/perfusion distributions in canine lung injury. Chest 1994; 106:1563-1569
19. Finer NN, Etches PC, Kamstra B, et al: Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose response. J Pediatr 1994; 124:302-308
20. Day RW, Guarín M, Lynch JM, et al: Inhaled nitric oxide in children with severe lung disease: Results of acute and prolonged therapy with two concentrations. Crit Care Med 1996; 24:215-221
21. Foubert L, Fleming B, Latimer R, et al: Safety guidelines for use of nitric oxide. Lancet 1992; 339:1615-1616
22. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012
23. Haddad IY, Ischiropoulos H, Holm BA, et al: Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 1993; 265: L555-L564
24. Haddad IY, Crow JP, Hu P, et al: Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am J Physiol 1994; 267:L242-L249
25. Young JD, Dyar O, Xiong L, et al: Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide. Intensive Care Med 1994; 20:581-584
26. Burger R, Bryan AC: Pulmonary hypertension after postlavage lung injury in rabbits: Possible role of polymorphonuclear leukocytes. J Appl Physiol 1991; 71:1990-1995
27. Tütüncü AS, Akpir K, Mulder P, et al: Intratracheal perfluorocarbon administration as an aid in the ventilatory management of respiratory distress syndrome. Anesthesiology 1993; 79: 1083-1093
28. Rovira I, Chen TY, Winkler M, et al: Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol 1994; 76:345-355
29. Lewis JF, Tabor B, Ikegami M, et al: Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol 1993; 74:1256-1264
30. Segerer H, van Gelder W, Angenent FWM, et al: Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique. Pediatr Res 1993; 34:490-494
31. Tütüncü AS, Faithfull NS, Lachmann B: Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndrome: Dose-dependent improvement of gas exchange. Crit Care Med 1993; 21:962-969
32. Lachmann B, Jonson B, Lindroth M, et al: Mode of artificial ventilation in severe respiratory distress syndrome. Lung function and morphology in rabbits after wash-out of alveolar surfactant. Crit Care Med 1982; 10:724-732